Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • United States Food and...

    Tag: United States Food and Drug Administration

    You Searched For "United States Food and Drug Administration"
    Cadila Healthcare gets EIR from USFDA for Baddi facility

    Cadila Healthcare gets EIR from USFDA for Baddi facility

    Medical Dialogues Bureau1 Nov 2019 8:41 AM GMT
    New Delhi: Drug firm Cadila Healthcare on Thursday said its Baddi facility in Himachal Pradesh has received establishment inspection report (EIR) from...
    Dr Reddys recalls Ranitidine products in US over cancer-causing impurity

    Dr Reddys recalls Ranitidine products in US over cancer-causing impurity

    Medical Dialogues Bureau24 Oct 2019 4:00 AM GMT
    This recall follows the USFDA's caution note alerting patients and healthcare professionals that NDMA was found in certain samples of ranitidine, Dr...
    Zydus Cadila gets USFDA nod for Colesevelam Hydrochloride tablets for lowering cholesterol

    Zydus Cadila gets USFDA nod for Colesevelam Hydrochloride tablets for lowering cholesterol

    Medical Dialogues Bureau10 Oct 2019 6:04 AM GMT
    Zydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to market Colesevelam Hydrochloride tablets,...
    Aurobindo Pharma Unit-7 gets 7 USFDA observations

    Aurobindo Pharma Unit-7 gets 7 USFDA observations

    Medical Dialogues Bureau8 Oct 2019 9:24 AM GMT
    The United States Food and Drug Administration (USFDA) conducted a Current Good Manufacturing Practices (CGMP) inspection at the company's unit-7...
    SPARC neonatal seizures drug Phenobarbital gets Orphan Drug Designation from USFDA

    SPARC neonatal seizures drug Phenobarbital gets Orphan Drug Designation from USFDA

    Farhat Nasim5 Oct 2019 6:30 AM GMT
    Orphan Drug Designation will grant seven years of US market exclusivity upon approval of Phenobarbital for the treatment of patients with neonatal...
    Cipla gets 12 USFDA observations for Goa facility

    Cipla gets 12 USFDA observations for Goa facility

    Medical Dialogues Bureau30 Sep 2019 9:45 AM GMT
    "The United States Food and Drug Administration (USFDA) conducted a cGMP inspection at our Goa manufacturing facility from September 16-27, 2019,"...
    Dr Reddys gets EIR from USFDA for manufacturing plants at Duvvada

    Dr Reddys gets EIR from USFDA for manufacturing plants at Duvvada

    Medical Dialogues Bureau13 Sep 2019 6:29 AM GMT
    The company has received EIR from the United States Food and Drug Administration (USFDA) for the inspection conducted at the formulations...
    Dr Reddys unveils generic version of Zyban ER tablets in US

    Dr Reddys unveils generic version of Zyban ER tablets in US

    Medical Dialogues Bureau5 Sep 2019 11:31 AM GMT
    The company has launched Bupropion hydrochloride extended-release tablets USP (SR), approved by the United States Food and Drug Administration...
    Lupin unveils generic version of Prozac tablets in US

    Lupin unveils generic version of Prozac tablets in US

    Medical Dialogues Bureau24 Aug 2019 4:15 AM GMT
    Fluoxetine tablet is a generic version of Eli Lilly and Company's Prozac tablets in the same strengths, Lupin said.Mumba: Pharma major Lupin Limited...
    Granules India gets 2 USFDA observations for Chantilly facility

    Granules India gets 2 USFDA observations for Chantilly facility

    Medical Dialogues Bureau23 Aug 2019 6:16 AM GMT
    "The United States Food and Drug Administration (USFDA) has completed inspection of the facility of Granules Pharmaceuticals Inc, a wholly-owned...
    Natco Pharma gets 6 USFDA observations for API facility near Hyderabad

    Natco Pharma gets 6 USFDA observations for API facility near Hyderabad

    Medical Dialogues Bureau13 Aug 2019 7:46 AM GMT
    Natco Pharma said it will provide due justifications and corrective action plan within the next 15 working days to address the USFDA observations.NEW...
    Natco Pharma gets EIR from USFDA for Kothur facility

    Natco Pharma gets EIR from USFDA for Kothur facility

    Medical Dialogues Bureau6 Aug 2019 11:05 AM GMT
    New Delhi: Drug firm Natco Pharma on Monday said it has received establishment inspection report (EIR) from the US health regulator for its Kothur...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:

    Search only trustworthy HONcode health websites:

    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    X